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Abstract 
To ascertain attitudes to resourcing, collaboration and publication in toxicology, a survey was 
developed and distributed to British Toxicology Society (BTS) members.  The survey comprised 14 
questions with 5 response options (strongly agree; agree; conflicted; disagree; strongly disagree) 
and a free text box.  One hundred completed surveys were received by the cut-off date for data 
analysis.  Unsurprisingly, 60% of participants disagreed or strongly disagreed that toxicology 
research is adequately funded in the UK; only 12% agreed with this statement.  A similar 
proportion of participants (53%) disagreed with the statement that funding councils give equal 
opportunity to toxicology whereas 31% were conflicted on this point.  An overwhelming 97% of 
respondents agreed that collaboration is important in driving toxicology research whereas only 
38% agreed that competition is important.  When this question was broadened out beyond the 
discipline of toxicology, a similar profile was seen suggesting that participants held similar views on 
toxicology versus other types of research.  Many respondents were conflicted regarding the role of 
competition both in toxicology and in other research disciplines.  Free text comments suggested 
that some competition is good to drive quality but can be counterproductive when competing for 
limited resources.  Most participants were in favour of making toxicology research data openly 
available (86%) and in favour of open access publication (89%) although there were reservations 
about the cost of open access.  Many (60%) thought the current system of peer review is fair but 
65% also supported the idea of double-blind peer review (where both reviewer and author are 
anonymized).  Others suggested a step in the opposite direction towards increased transparency 
(revealing and holding reviewers to account) would be preferable.  Overall, there was a broad 
theme in free text responses that the need for experienced toxicologists has increased at a time 
when training and investment in the discipline has declined.  However, not all respondents held 
that view with some noting that toxicology both as a research and as an applied discipline is strong 
within the UK scientific community.
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Introduction
Controversial topics such as the use of animals in research, health scares around food 
contamination or adverse events in clinical trials have often placed toxicology in the focus of both 
scientific and societal concern.  Toxicologists are challenged by the necessity to keep the discipline 
current, relevant and ethical amidst the plethora of emerging issues and technologies.  We 
previously explored the ethical concerns of conflict of interest (COI), transparency, reproducibility 
and funding of animal research and suggested new ways of working for discussion.1  This opinion 
paper triggered a number of questions and areas to explore regarding current attitudes to 
toxicology research in the UK.  In addition to these ethical concerns, many believe that toxicology 
as a discipline is under threat from several directions both in the UK and in Europe.  As highlighted 
in a 2016 letter from EUROTOX, the European Federation of Toxicology Societies2, these threats 
include reduced resourcing and a reduction in the number of academic posts and training places.    
To address current attitudes of toxicologists to challenges to their discipline, we developed a 
survey intended to elicit the views of current practitioners of the discipline.  This larger survey was 
based on the outcome from a pilot survey distributed to a small group of toxicologists seeking 
responses to posed questions but also seeking feedback on process and survey format (Masters’ 
Research Project Study conducted by E Walker; unpublished data).   Based on the outcome of this 
pilot, a larger survey was developed and distributed to British Toxicology Society (BTS) members 
and toxicology conference participants asking for opinions on resourcing, collaboration, 
competition, research infrastructure and peer review.  Herein we present the outcome of this 
research.  Conclusions are focused on UK toxicology but are clearly relevant to many aspects of 
scientific research in the UK and elsewhere.  
Experimental
A survey comprising 14 questions (Table 1) was prepared to explore different aspects of attitudes 
to toxicology funding, peer review and publication (see ESI 1 for full survey format). In the pilot 
survey, 7 questions on toxicology research were posed to 12 volunteers seeking responses to the 
questions but also feedback on survey format. Based on the comments received, several 
modifications were made to the questions posed and to the survey format including the addition of 
the open text box so respondents could provide explanations for their answers.  
The survey was accompanied by a participants’ information sheet (see ESI 2) that explained the 
purpose of the study and information around data protection and confidentiality.  The survey and 
participants’ information sheet were reviewed and approved by the Executive Committee of the 
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BTS for distribution to BTS members and BTS conference participants.  The survey was distributed 
by the BTS Secretariat via a web link.  
Anonymized responses were collated into an excel spreadsheet for analysis and review.  At the 
date preset for the close of the survey, one hundred responses had been received.  Thus, data are 
presented as actual numbers of respondents but can also be quoted as percent response.   Since 
the survey was set up as an exploratory study the data are presented as a descriptive analysis of 
results.   Not all data add up to the 100 respondents since there were some non-responders (0-4 
people) for some questions.  Although data were anonymized, each respondent had a ‘respondent 
number’ preserved across all questions allowing for an analysis of internal pairings of answers.  
Raw data, plots and pivot tables are available in ESI 3.
Results and Discussion
 
Views on Resourcing in Toxicology (Q1 and Q2)
Only 12% of respondents agreed that toxicology research is adequately funded in the UK (Figure 
1).  The majority of respondents (60%) disagreed or strongly disagreed with this statement.  With 
reference to research councils and other bodies providing equality of opportunity to toxicology 
research, only 13% of respondents agreed this was true (Figure 1) with 52% disagreeing/strongly 
disagreeing with this statement.  Around 30% of respondents were conflicted in their responses to 
these two questions.  It’s notable that the two profiles for Q1 and Q2 are very similar which could 
suggest that individual participants responded similarly to the two questions.  However, a pairing 
analysis suggested this wasn’t necessarily the case; the highest concordance between the two 
questions was in ‘disagree’ yet only 15 of the 41 participants who disagreed with Q1 also 
disagreed with Q2.  This suggests, as affirmed by the free text answers, that equality of opportunity 
is not the only issue in funding. In this context, respondents highlighted both Tox213 and ToxCast4 
as great examples of investment in toxicology by the US government, delivering a transformation in 
the profile of toxicology.
The disagree/strongly disagree category for Q1/Q2 yielded more free text answers than any other 
questions in the survey.  Comments fell broadly into three categories (table 2) around reductions in 
training/resourcing/career guidance, lack of appreciation of the value of the discipline and a third 
category of relatively emotive statements.  One comment summarized an overall view expressed 
by those that disagreed/strongly disagreed that toxicology is adequately resourced: ‘Academic 
centres have reduced, government spending over a long period has been minimal, pharmaceutical 
companies have relocated or contracted, CRO's do not have development of the science at their 
core purpose’.  Several respondents highlighted that many pharmaceutical companies have 
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contracted in the UK.  While this may be true, the Association of the British Pharmaceutical 
Industry (ABPI) data5 shows that the number of pharmaceutical enterprises in the UK rose steadily 
between 2012 and 2015 (the last year in the survey).  ABPI data also show that the number of 
people employed has stayed relatively constant at around 60 – 65 thousand employees over the 
last decade since 2009. 5   A possible explanation of this apparent discrepancy in views is that while 
large pharma is contracting, the UK small and medium enterprise (SME) biotech sector is booming 
with 2019 figures showing a 40% increase in investment. 6
Overall, there was a broad theme that the need for experienced toxicologists has increased at a 
time when training and investment in the discipline has declined. Also notable in the free text 
comments was a concern around sustainability and a perception that toxicology in the US is still 
well resourced as summarized by this participant:  ‘Although there is a fair amount of toxicology 
research underway in the UK it is clearly not as well-resourced as toxicology research elsewhere in 
the world such as the USA’.   Also notable was the perspective from one early career scientist who 
stated that ‘As a student hoping to enroll on a toxicology associated PhD, my experience in looking 
for such opportunities suggests that projects of a toxicological nature are far less common than 
those in alternative biological/pharmaceutical areas.’  
Of the 12 participants that agreed or strongly agreed that toxicology was adequately resourced in 
the UK, several provided free text comments primarily on two themes.  Firstly, that hazard and risk 
assessments are adequately done in the UK.  Secondly, that toxicology is a multidisciplinary 
science and therefore training in other disciplines feeds the pool of toxicologists.  This second 
theme touches on a concept explored in the initial opinion article1 where we proposed that 
toxicology must be willing to redefine its boundaries as a discipline and draw strength and diversity 
from other sciences.  One important discussion point regarding resourcing of toxicology is the 
distinction between education and training.  In general terms, training refers to imparting a special 
skill or behavior to a person and is often delivered ‘on the job’ and/or in applied training courses.  It 
is not the same as education, which is usually delivered by an institution with the aim of developing 
a sense of judgment and reasoning that can be applied to any topic or problem.  Thus, scientists 
who have received an education in topics such as biochemistry, pharmacology, medicine, 
veterinary sciences, physiology and mathematics are all great potential toxicologists, but a training 
course coupled with significant ‘on the job’ experience is required to transform such individuals into 
toxicologists.  Thus, postgraduate training courses in toxicology should be supported and 
expanded.      
 
 
Views on Collaboration and Competition in Toxicology (Q3-6)
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Overall, respondents were enthusiastic about collaboration.  An overwhelming 97% of respondents 
agreed that collaboration is important in driving toxicology research in the UK (Q3; Figure 2A).  
Notably, no respondent disagreed with this statement. This is not surprising since it is difficult to 
think of a downside to collaboration as a concept.  When this question was broadened out beyond 
the discipline of toxicology (Q4), most participants disagreed that collaboration is uniquely 
important in driving toxicology research.  Thus, participants were in favour of collaboration in 
toxicology and in other disciplines.  However, opinions around competition were more conflicted.  
When similar questions were asked regarding the role of competition in driving toxicology research 
(Qs 5 & 6), a very different profile emerged; roughly equal numbers of respondents agreed/strongly 
agreed (38) versus disagreeing/disagreeing (30) with the statement that competition is important in 
driving toxicology research (Figure 2B).  When the question on competition was broadened out 
beyond the discipline of toxicology, a similar profile was seen, suggesting that participants held 
similar views on the role of competition in toxicology versus other types of research.  
A pairing analysis (table 3) produced a notable pattern in concordance around collaboration: of the 
71 participants who strongly agreed with Q3 (collaboration is important in toxicology), 42 of them 
also strongly agreed with Q4 (collaboration is uniquely important in toxicology).   Looking at this the 
other way around, 92% (46/50) of those who strongly agreed with Q4 also strongly agreed with Q3.  
Questions (5 & 6) regarding competition in toxicology and other disciplines produced a high 
number of conflicted responses (32 and 37, respectively).  A pairing analysis showed that 26 
respondents were conflicted over both questions.  The overall theme of the ‘conflicted’ free text 
comments on the role of competition in driving research was that some competition is good to drive 
quality but that it can be counterproductive when groups are competing for limited resources.  This 
raises an interesting point in that competition is regarded as intrinsic to the conduct of research in 
any discipline, including toxicology.  For example, researchers compete for grant funding, journal 
space, training positions and jobs; this is generally regarded as an important step in ensuring 
quality.  However, if competition is taken to extremes it can prevent effective collaboration; these 
aspects of toxicology (when to compete and when to collaborate) are more about scientists 
possessing the interpersonal skills to ensure appropriate and constructive behaviour rather than 
about the scientific discipline per se.  In this regard, perhaps ‘responsible competition’ should be 
highlighted in degree courses and career and professional training programmes.
To understand if there is a relationship between concern around resources and concern around the 
role of competition, a pairing analysis was conducted to see how those that disagreed with Q1 
(toxicology research Is adequately funded) responded to Q5.  Of the 41 respondents who 
disagreed that toxicology is adequately resourced, 17 of them agreed that competition plays a 
positive role in driving toxicology research and 8 of them were conflicted on this statement.   Thus, 
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it would seem that concern over adequate resourcing is not the main driver for a dislike of 
competition among some participants.
Views on Research Infrastructure (Q7)
Only 25% of participants agreed or strongly agreed that there is a good infrastructure to support 
research between academia, industry and the regulatory authorities (Figure 3).  Many more (43) 
disagreed or strongly disagreed with this statement.  Again, there were many respondents (32) that 
reported being conflicted on this question.  Free text reasons for the conflict fell into three broad 
categories (table 4): room for improvement, role of the individual and COI.  Under ‘Room for 
improvement’, participants generally highlighted positive aspects such as collaboration between 
academia and industry that they would like to see more of.  Under ‘Role of the individual’, there 
was a lot of emphasis on interpersonal skills which echoes comments made earlier around 
‘responsible competition’.   One respondent specifically mentioned the positive role played by the 
BTS in supporting research infrastructure.  This question highlights an opportunity to improve 
support and infrastructure in toxicology.  
   
Views on Open Access (Q8 & 14a)
Most participants (86%) were strongly in favour of making toxicology research data openly 
available (Figure 4) with only 2 disagreeing that this was a good idea.  Similarly, most participants 
were strongly in favour of open access publication with only 3% disagreeing that this is a good 
idea.  It’s notable that the profiles of responses to these two questions on open access are largely 
similar overall with 41% of respondents agreeing with both statements (see Figure 4) and with 
good internal concordance in response.  For example, of the ‘strongly agree’ for question 8 (45 
participants), 33 (73%) of these individuals also strongly agreed with question 14a .  These two 
questions were generally met with decisive opinions in respondents, with few participants 
answering ‘conflicted’ on question 8/14a (12/8 participants, respectively).  Only one participant 
reported feeling conflicted on both of these statements suggesting that views on open access were 
quite clear amongst the respondents.  
Some of the comments regarding open access were as expected with strong support for scientists 
to access useful information.  Others commented that data sharing can help avoid duplication of 
animal experimentation.  However, there were some potentially controversial free text comments 
largely from those who agreed that it was a good idea; specifically, one participant stated that 
‘Most publishers bring very little value added to the table, and are exploiting the voluntary efforts of 
others to make large profits’ and another that ‘…..publishing houses are taking the scientific 
community for a ride. You don't even get access to your work unless you have subscription or 
access to one.’  These opinions reflect a recent trend in pushing back on publishing strategies as 
illustrated by the University of California which has decided not to renew its journal subscriptions 
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with Elsevier in a disagreement over ‘the rapidly escalating costs associated with for-profit 
journals.’ 7 
Views on Conflict of Interest (Q9 & 11)
Conflict of interest (COI) emerged as an important consideration for the survey respondents; the 
majority agreed or strongly agreed (69%) that they consider whether there is a COI when reading 
research publications (Figure 5).  Only 17% disagreed with the statement.  Similarly, most 
participants agreed or strongly agreed (68%) that they consider whether there is a COI when 
reviewing research publications (Figure 5) with only 3% disagreeing with this statement.   It’s 
notable that the profiles of responses to the two COI questions are largely similar overall (see 
Figure 5) and there was also good internal concordance in response.  For example, of the ‘strongly 
agree’ for question 9 (49 participants), 31 (63%) of these individuals also strongly agreed with 
question 11.  
Free text comments offered more detail on opinions on COI.  Several participants commented that 
considering COI was a very important issue and was ‘self-evident’.  Others stated that they would 
decline to review if there was COI.    There were also several free text comments to clarify what 
COI meant to individual participants: ‘…..only if it is a REAL conflict of interest rather than inferred 
just because of employer or sources of grant funding’.  Rather than decline to review, others 
suggested that if they perceived COI then they would ‘be more insistent on approaching every 
sentence with the mindset of an auditor -  Can the statement be fully supported backed up by data 
that is presented if it can't be supported, are more data required or should the statement be edited 
or removed?’  The topic of COI came up also in the free text responses to Question 7 on research 
infrastructure (Table 4).  Specifically, participants commented that real or perceived COI could be a 
block to the creation and maintenance of the effective research infrastructure networks needed to 
drive a multidisciplinary subject such as toxicology.  
  
There were a few participants that were conflicted on questions 9 and 11, but only 3 participants 
reported being conflicted on both of these statements.  Most of the free text comments on 
‘conflicted’ for questions 9 and 11 were around the participant feeling unable to comment due to 
lack of knowledge of current systems.    
The data and freetext responses show that COI was clearly an issue of concern amongst survey 
participants, with several highlighting the need to distinguish between real and perceived COI.  COI 
was helpfully defined in 2017 as ‘….a set of circumstances that creates a risk that professional 
judgement or actions regarding a primary interest will be unduly influenced by a secondary interest’
. 8 Clearly, circumstances that create a real risk of COI are to be avoided.  However, what is meant 
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by perceived COI?  It was pointed out more than a decade ago that COI is being used in 
gamesmanship where, for example, ‘strong assertions of conflict of interest are used to justify 
particular points of view’. 9  This challenge still persists today with ongoing attention on COI and 
some unfortunate consequences such as the exclusion of industry scientists from governmental 
panels and review committees. 8  
Views on Peer Review (Q10, 12 & 13)
Overall, the survey respondents favoured the current peer review system with the majority (60%) of 
respondents agreeing or strongly agreeing that the current system of peer review is fair with only 
7% disagreeing or strongly disagreeing with this statement (Figure 6).  Interestingly, 65% also 
agreed or strongly agreed that double blind peer review (where both reviewer and author are 
anonymized) is a good idea with only 11% disagreeing/strongly disagreeing.  Since most journals 
currently do not use double blind peer review, these answers could be hard to interpret.  However, 
the free text responses to agree/strongly agree with Q13 offer some explanation; broadly speaking, 
participants support the need for peer review and support the current system but feel that double 
blind review is ‘an interesting idea’ or ‘worth a go’.  Looking at internal data comparisons, of the 56 
participants that agreed that the current system of peer review is fair, 10 were conflicted and 6 
disagreed/strongly disagreed with double blind peer review.  
There were some interesting points raised in the free text from those both in favour of and against 
double blind peer review (Table 5).  Many disputed the value and feasibility; others suggested that 
a step in the opposite direction towards increased transparency (revealing and holding reviewers to 
account) would be preferable.
In this survey we only asked about the currently prevalent system of peer review (where reviewers 
are anonymous) and attitudes to double blind peer review.  However, there are other systems that 
can be considered such as “Open Peer Review” (OPR) and triple blind peer review (where authors 
and their institutions are reciprocally anonymous to reviewers and editors). 10   In their review, 
Tennant et al 10 present a detailed analysis to consider the pros and cons of these various 
systems.  
Some participants agreed (30) or strongly agreed (7) that reviewers are not sufficiently trained to 
judge the merit, quality and impact of toxicology research.  However, 21% disagreed/strongly 
disagreed with this statement.  A large number (41%) were conflicted on this point, the highest 
number of conflicted answers for any of the questions in the survey.  There were very few free text 
answers offered by those who disagreed with this question.  However, those who agreed/strongly 
agreed (that reviewers are not sufficiently trained) offered free text answers mainly drawn from 
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negative personal experience with comments such as ‘this is very clear from some of the referees’ 
comments I received in the past’ and ‘Often they seem to miss point’.  Many of the conflicted 
respondents offered similar views that were well summarized by one participant; ‘It is mixed. Some 
are excellent. Some very dismissive and some simply do not understand the science.’  
It may be useful to follow this survey with a more detailed analysis of views of the BTS towards 
peer review. There is also the opportunity to offer training to BTS members and other toxicologists 
based around the 6-red flags rules described by Begley11  .These flags include such fundamental 
issues as inappropriate reagents, lack of reproducibility and absence of controls .   Steps have 
been proposed to overcome this for toxicology as a discipline12; the BTS could play a role in 
delivering an integrated and unified approach to address COI, peer review and unreproducible data 
across all basic and applied pharmacology and toxicology1.  
Other Observations
Several other themes emerged in the free text comments offered by participants, mainly by those 
who were concerned regarding declining resourcing of toxicology and the overall sustainability of 
the discipline.  The BTS was mentioned as a key arena for collaboration but with the caveat that 
collaboration is optional and not to be mandated.  
ITTP (MRC Integrative Toxicology Training Partnership)13 was also mentioned by several 
participants as a great scheme, typified by the following comment:  ‘It took huge effort to get the 
ITTP programme to work - but it is very limited in comparison to other sectors and review panels 
rarely have toxicologists evaluating the merit of applications for funding.’   Two other key themes 
were: 1. the decline of Centres of Excellence for Toxicology Research such as Central Toxicology 
Laboratory and Bibra which were instrumental in many aspects such as driving research, training 
and collaboration and 2. The decline of toxicology training centres as illustrated by this quote: ‘
There are not enough training locations for Tox in the UK. Only Birmingham offers a full-time and 
part-time MSc course. The community is still reeling from the closure of the Surrey course’.  
Limitations of the survey and its interpretation 
There are several limitations to this survey and its interpretation.   Firstly, the survey was set up as 
an exploratory study; as such the data are presented as a descriptive analysis of results.  
Secondly, the sampling strategy is inherently biased since it seeks the views just of BTS members 
without a suitable reference group (with and/or without scientific expertise) – thus it is not possible 
to determine the degree of 'expert bias' in the data.  Thirdly, only a limited proportion of BTS 
members responded; it is possible that those that did respond chose to do so since they hold 
strong views on the survey topics and as such may not be representative of the wider views of the 
BTS membership.  
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Conclusions
This report assessed the attitudes of toxicologists to challenges in their discipline. The results of 
the survey suggest that there is a persistent concern around resourcing, training and sustainability 
for the discipline of toxicology within the UK community.  There is a recognition that much can be 
achieved with limited resources via collaboration especially across the sectors of academia, 
industry and government but that perceived COI can sometimes be a barrier to this collaboration.   
Interestingly, there were split views on the role of competition since it can drive innovation but can 
also be counterproductive if scientists are competing for limited resources.  In this respect, there 
may be a role for the BTS in propagating ‘responsible competition’ where competition ensures 
quality but is not a barrier to collaboration.  The survey also suggests that we need to take a fresh 
look at peer review of both grants and papers and consider either double blind peer review or more 
interestingly, a move towards more transparency where reviewers are no longer anonymous. Also 
relevant is to drive greater awareness of the 6-red flags11; this would ensure that all scientists 
reviewing toxicology data either in the context of grant proposals or papers could avoid common 
pitfalls.  Other concerns emerged on the cost of open access and some concern over who pays 
these charges.  Overall, there was a broad theme in free text responses that the need for 
experienced toxicologists has increased at a time when training and investment in the discipline 
has declined.  However, not all respondents held that view with some noting that toxicology both as 
a research and as an applied discipline is strong within the UK scientific community.  An 
informative area for future research would be to explore how views differ across public versus the 
private sector and also if there are differences in views between early and later career 
toxicologists.   
Conflict of interest
Ruth Roberts is co-founder and co-director of Apconix, an integrated toxicology and ion channel 
company that provides expert advice on nonclinical aspects of drug discovery and drug 
development to academia, industry and not-for-profit organisations.  Jason Gill is chair of the BTS 
scientific sub-committee and member of the executive committee. He is also co-founder of 
Incanthera, an oncology drug discovery company. 
Acknowledgements
The authors would like to acknowledge Marie South, Chartered Statistician for her advice on data 
analysis.  
This work was supported by a BTS Summer Vacation Scholarship awarded to Emma Walker and 
supervised by Jason Gill.
Page 11 of 24 Toxicology Research
To
xi
co
lo
gy
R
es
ea
rc
h
A
cc
ep
te
d
M
an
us
cr
ip
t
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
3 
M
ay
 2
01
9.
 D
ow
nl
oa
de
d 
on
 5
/1
3/
20
19
 3
:0
9:
20
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/C9TX00063A
References 
1. Walker E and Roberts R (2018).  Collaboration and competition: ethics in toxicology.  
Toxicol. Res 7: 576-585.
2. Wallace H, Roberts R, Corsini E, Bonefeld-Jorgensen E, Orhan H, Mach M, Weiser T, 
Carvalho F, Iscan M, Tsatsakis A (2016). Toxicology as an academic discipline in European 
Universities.  Toxicol. Lett. 254: 63.
3. Collins FS, Gray GM, Bucher JR (2008). Transforming environmental health protection. 
Science 319:906.
4. Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ (2007): The ToxCast 
program for prioritizing toxicity testing of environmental chemicals. Toxicological Sciences  
95:5-12.
5. https://www.abpi.org.uk/facts-and-figures/ 
6. https://www.biopharma-reporter.com/Article/2019/03/27/Investment-in-UK-biotech-is-up-40-
in-2019
7. The Bookseller (2019) https://www.thebookseller.com/news/university-california-boycotts-
elsevier-965166
8. Dietrich DR and Hengstler JG (2016). Conflict of interest statements: current dilemma and 
a possible way forward. Arch Toxicol.  90: 2293-2295.  
9. Purchase IFH (2004). Fraud, errors and gamesmanship in experimental toxicology. Toxicol. 
202: 1-20. 
10. Tennant JP, Dugan JM, Graziotin D et al. (2017). A multi-disciplinary perspective on 
emergent and future innovations in peer review. F1000Research. 6:1151-1156.  
11. Begley G (2013). Six red flags for suspect work, Nature. 497:433-434.
12. Miller G (2014). Improving reproducibility in toxicology. Toxicol. Sci. 139:1-3.  
13. MRC ITTP https://www.mrc-tox.cam.ac.uk/postgraduate/ittp-integrative-toxicology-training-
partnership
Page 12 of 24Toxicology Research
To
xi
co
lo
gy
R
es
ea
rc
h
A
cc
ep
te
d
M
an
us
cr
ip
t
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
3 
M
ay
 2
01
9.
 D
ow
nl
oa
de
d 
on
 5
/1
3/
20
19
 3
:0
9:
20
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/C9TX00063A
Fig. 1.  Views on Resourcing in Toxicology.  Responses to two questions are shown:  "I believe 
toxicology research is adequately resourced in the UK (blue) and "When compared to other 
disciplines, I believe the research funding councils and other funding bodies provide equality of 
opportunity to facilitate toxicology research" (grey).   
Page 13 of 24 Toxicology Research
To
xi
co
lo
gy
R
es
ea
rc
h
A
cc
ep
te
d
M
an
us
cr
ip
t
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
3 
M
ay
 2
01
9.
 D
ow
nl
oa
de
d 
on
 5
/1
3/
20
19
 3
:0
9:
20
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/C9TX00063A
Fig. 2.  Views on Collaboration and Competition in Toxicology.  (A) Responses to two 
questions are shown:  "I believe collaboration to be important in driving toxicology research in the 
UK’’ (blue) and ‘’When compared to other disciplines, I believe collaboration to be especially 
important in driving toxicology research’’ (grey).  (B)  Responses to two questions are shown:  "I 
believe competition to be important in driving toxicology research in the UK’’ (blue) and ‘’When 
compared to other disciplines, I believe competition to be especially important in driving toxicology 
research’’ (grey).  
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Fig. 3.  Views on Research Support Infrastructure. Responses to one question are shown "I 
believe believe there is a good infrastructure to support research between academia, industry and 
the regulatory authorities".    
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Fig. 4. Views on Open Access.  Responses to two questions are shown ‘’I believe making 
toxicology research data openly available with as few restrictions as possible in a timely and 
responsible manner would improve the impact and efficiency of toxicological research’’ (blue) and 
‘’I believe open access publication, where articles are available free at source, is a good idea’’ 
(grey).  
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Fig. 5. Views on Conflict of Interest.  Responses to two questions are shown ‘’When reading 
research publications, I consider whether there is a conflict of interest when assessing the validity 
of research’’ (blue) and ‘’When peer reviewing research publications, I consider whether there is a 
conflict of interest when assessing the validity of research" (grey).  
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Fig. 6 Views on Peer Review.  Responses to three questions are shown ‘’I believe the current 
system of peer review for research outputs is a fair and appropriate system’’ (blue), ‘’I believe 
reviewers are often not sufficiently trained to adequately and fairly judge the merit, quality and 
impact of toxicology research’’ (grey) and ‘’ "I believe double-blind peer review, where both 
reviewer and author are anonymised, is a good idea"’’ (green).    
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Table 1:  Questions by number and response options
Number Question Response Options
1 I believe toxicology research is adequately resourced in the UK
2 When compared to other disciplines, I believe the research funding councils and other funding 
bodies provide equality of opportunity to facilitate toxicology research
3 I believe collaboration to be important in driving toxicology research in the UK
4 When compared to other disciplines, I believe collaboration to be especially important in driving 
toxicology research
5 I believe competition to be important in driving toxicology research in the UK
6 When compared to other disciplines, I believe competition to be especially important in driving 
toxicology research
7 I believe there is a good infrastructure to support research between academia, industry and the 
regulatory authorities
8 I believe making toxicology research data openly available with as few restrictions as possible in a 
timely and responsible manner would improve the impact and efficiency of toxicological research
9 When reading research publications, I consider whether there is a conflict of interest when 
assessing the validity of research
10 I believe the current system of peer review for research outputs is a fair and appropriate system
11 When peer reviewing research publications, I consider whether there is a conflict of interest when 
assessing the validity of research
12 I believe reviewers are often not sufficiently trained to adequately and fairly judge the merit, 
quality and impact of toxicology research
13 I believe double-blind peer review, where both reviewer and author are anonymised, is a good idea
14a I believe open access publication, where articles are available free at source, is a good idea
Strongly Agree
Agree
Conflicted
Disagree
Strongly Disagree
14b Have you published research outputs using an open access route in the last two years? Yes
No
14c If so, how was the cost for publication supported? Institute or Employer 
Collaborator or industry sponsor
Competitive research award
Competitive research award (co-author)
Funded personally
Not applicable
Other (free text)
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Table 2.  Free text comments to question 1. 
Theme Overall point Example answers
Disagree/strongly 
disagree
Lack of appreciation of 
the value of the 
discipline
it is virtually impossible to obtain research council funding for toxicology-based research they are just not 
interested.
Not enough input
Not enough being done to drive the discipline forward
It’s like the forgotten science, despite being front and central to many areas.  
Training, research and 
career development 
much reduced
As a early career researcher, I have noticed that any toxicology-related education or career advice have 
been effectively absent throughout my undergraduate and postgraduate studies
Not promoted as an effective career
No resources for research
Emotive statements We are screaming out for studies to be done
Why would drug companies want to identify problems!
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Table 3.  Concordance in responses between Q3 and Q4.  Paired answers are highlighted in grey.
Q4: When compared to other disciplines, I believe collaboration to be especially important in driving 
toxicology research
Agree Conflicted Disagree Strongly Agree (blank) Grand Total
Agree 16 2 3 4 1 26
Conflicted 1 1 2
Strongly Agree 15 7 3 46 71
(blank) 1 1
Q3: I believe 
collaboration to 
be important in 
driving 
toxicology 
research in the 
UK
Grand Total 32 10 7 50 1 100
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Table 4.  Free text responses to question 7 (research infrastructure). 
Theme Overall point Example answers
Conflicted Mixed – room for 
improvement 
The collaboration is present at the BTS congress and other meetings. Otherwise interactions can be limited 
especially with regulatory agencies.
There are good industry/academic links, but we should harness these links more broadly rather than 
company by company
There could be more done to support this.
In some instances I agree, however more collaboration between more academic departments and institutes 
would be welcome instead of just a few working with industry.
Yes and No - my issue is that on the whole regulatory authorities do a good job, but they are often difficult 
to deal with and can be fairly unhelpful. It should be more a collaborative approach.
It’s about individuals I think it depends on the individual authorities/ institutions
I have experience of when the different areas have worked well together. But this has been down to the 
good will of the individuals concerned, rather than anything that stems from government funded actions.
Where it works well it's about networks & personal relationships rather than infrastructure - depends on 
individuals' commitment to making something happen ...
Real or perceived COI Mixed feelings here. On the one hand academic institutions are forced to cooperate with other partners 
due to declining funding from government bodies. On the other hand society is suspicious to this 
cooperation. Moreover, many regulatory authorities want to be "independent" and not very keen on 
cooperation.
For some collaborations this exists but the perception of the conflicting interests of these 3 organisations 
often prevents effective collaboration.
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Table 5.  Free text responses to question 12 (double blind peer review). 
In favour Against
Anonymity Gives more 
opportunity to 
unknown and up-and-
coming groups
It’s good to know the group’s history and reputation
It doesn’t take much to work out who the authors are and where they are from
I am happy to be identified as a reviewer and would prefer that rather than blinding the authors
Process Not sure how this 
would work
 
It’s too complex
Already too time consuming – this would make it worse
Is this even feasible?
Value It seems fairer
Good to decide purely 
based on what is 
presented
I can’t see how this would help
Is there a problem to fix?  
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TOC Entry
BTS members offer their opinions and interesting suggestions for improvement around resourcing, 
collaboration, competition, infrastructure and peer review in toxicology.  
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